Rats treated with three daily urocortin 1 (UCN) injections into the basolateral amygdala (BLA; i.e., UCN/ BLA-primed rats) develop prolonged anxiety-associated behavior and vulnerability to panic-like physiological responses (i.e., tachycardia, hypertension and tachypnea) following intravenous infusions of 0.5 M sodium lactate (NaLac, an ordinarily mild interoceptive stressor). In these UCN-primed rats, the osmosensitive subfornical organ (SFO) may be a potential site that detects increases in plasma NaLac and mobilizes panic pathways since inhibiting the SFO blocks panic following NaLac in this model. Furthermore, since SFO neurons synthesize angiotensin II (A-II), we hypothesized that the SFO projects to the BLA and releases A-II to mobilizing panic responses in UCN/BLA-primed rats following NaLac infusions. To test this hypothesis, rats received daily bilateral injections of UCN or vehicle into the BLA daily for 3 days. Five to seven days following the intra-BLA injections, we microinjected either the nonspecific A-II type 1 (AT1r) and 2 (AT2r) receptor antagonist saralasin, or the AT2r-selective antagonist PD123319 into the BLA prior to the NaLac challenge. The UCN/BLA-primed rats pre-injected with saralasin, but not PD123319 or vehicle, had reduced NaLac-induced anxiety-associated behavior and panic-associated tachycardia and tachypnea responses. We then confirmed the presence of AT1rs in the BLA using immunohistochemistry which, combined with the previous data, suggest that A-II's panicogenic effects in the BLA is AT1r dependent. Surprisingly, the SFO had almost no neurons that directly innervate the BLA, which suggests an indirect pathway for relaying the NaLac signal. Overall these results are the first to implicate A-II and AT1rs as putative neurotransmitter-receptors in NaLac induced panic-like responses in UCN/BLA-primed rats.
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Introduction
Panic disorder is a severe anxiety disorder characterized by recurrent panic attacks, consisting of pronounced fear and heightened cardiorespiratory responses (DSM-IV, 1994) . A unique characteristic of panic disorder patients is their sensitivity to ordinarily mild interoceptive stressors such as intravenous infusions of mildly hypertonic 0.5 M sodium lactate (NaLac) (Cowley et al., 1987; Lapierre et al., 1984; Liebowitz et al., 1985) . The pathological sensitivity to interoceptive stressors appears to involve an alteration somewhere in the central neural pathways controlling normal panic responses. The amygdala may be part of this circuitry since abnormalities in this structure have been noted in panic patients (Reiman et al., 1984 (Reiman et al., , 1989 Wiest et al., 2006) .
The amygdala plays a critical role in attention mechanisms that facilitate learning and survival in response to important sensory input [see review (LeDoux, 2000) ]. Synaptic plasticity changes within the basolateral amygdala (BLA) parallel anxiety-like behavior and are believed to be important in fear-associated memories (Mitra et al., 2005) . Preclinical data from our laboratory support the hypothesis that aberrant conditions within the amygdala underlie panic attacks in some cases. For instance, chronic loss of local inhibitory GABAergic tone (Sajdyk and Shekhar, 2000; Shekhar et al., 1999) , or three daily injections of urocortin 1 (UCN, a potent corticotropin-releasing factor 1 and 2 receptor agonist) (Rainnie et al., 2004; Sajdyk et al., 1999a) 
